文献速递瓣膜外科

二叶式主动脉瓣合并单纯主动脉瓣反流成人患者中的Ross手术:20年免于再手术率85%

The Ross procedure in adults presenting with bicuspid aortic valve and pure aortic regurgitation: 85% freedom from reoperation at 20 years.
PubMed 文献 · Eur J Cardiothorac Surg · 2018-01-01

分析1993至2016年129例二叶式主动脉瓣合并单纯主动脉瓣反流、平均年龄34.7±10.6岁的成人患者接受Ross手术的结果,平均随访9.6±6.8年,20年免于主动脉瓣置换再手术及残余反流超过轻度者为85%,作者认为应考虑在此类患者中应用Ross手术。

要点

  • 二叶式主动脉瓣合并单纯主动脉瓣反流患者Ross术后20年免于再手术及残余反流超过轻度者为85%。
  • 术后10年与20年生存率分别为99%(95%CI 94-100)与95%(95%CI 85-99)。
  • 更长的主动脉阻断时间、体外循环时间及更大的术前窦管交界直径与再手术或显著反流相关。

核心结论

  • 二叶式主动脉瓣合并单纯主动脉瓣反流患者Ross术后20年免于再行主动脉瓣置换及残余反流超过轻度者为85%,作者认为应考虑在此类患者中应用Ross手术。

研究设计与样本

  • 回顾性分析1993年至2016年连续129例二叶式主动脉瓣合并单纯主动脉瓣反流、接受Ross手术的患者,平均年龄34.7±10.6岁(范围16-64岁)。
  • 患者每年随访,随访期间每两年行经胸超声心动图检查。
  • 本中心再手术策略宽松,随访期间出现复发性中度或以上主动脉瓣反流即行再手术。

主要发现

  • 院内死亡1例,平均随访9.6±6.8年期间晚期死亡3例。
  • 术后10年与20年晚期生存率分别为99%(95%CI 94-100)与95%(95%CI 85-99)。
  • 11例患者再行主动脉瓣置换,4例患者再行肺动脉瓣置换。
  • 术后10年与20年免于主动脉瓣置换再手术及反流超过轻度者分别为89%(95%CI 81-94)与85%(95%CI 74-92)。
  • 更长的主动脉阻断时间(HR 1.03,95%CI 1.00-1.06;P=0.05)、更长的体外循环时间(HR 1.02,95%CI 1.00-1.05;P=0.05)及更大的术前窦管交界直径(HR 1.15,95%CI 1.03-1.30;P=0.02)是随访期间再行主动脉瓣置换或显著反流的显著预测因素。

临床怎么用

  • 本中心再手术策略为随访期间出现复发性中度或以上主动脉瓣反流即行再手术。
  • 作者认为,基于20年免于再行主动脉瓣置换及残余反流超过轻度者为85%的结果,应考虑在二叶式主动脉瓣合并单纯主动脉瓣反流患者中应用Ross手术。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The Ross procedure has demonstrated excellent results when performed in patients with aortic stenosis or mixed aortic valve disease [aortic stenosis and aortic regurgitation (AR)]. However, due to its reported risk of late reoperation, it is not recommended under current guidelines for patients presenting with bicuspid aortic valve and pure AR. We have analysed our own results in light of this recommendation. METHODS: Between 1993 and 2016, 129 consecutive patients with a mean age of 34.7 ± 10.6 years (range 16-64 years) presented with bicuspid aortic valve and pure AR and underwent the Ross procedure. Patients were reviewed annually and had 2nd yearly transthoracic echocardiograms during follow-up. The unit had a liberal reoperation policy where reoperation was performed if patients developed recurrent moderate or greater AR during follow-up. RESULTS: There was 1 inpatient death, and 3 late deaths over a mean follow-up duration of 9.6 ± 6.8 years. Late survival at 10 and 20 years post-surgery were 99% [95% confidence interval (CI) 94-100] and 95% (95% CI 85-99), respectively. Eleven patients underwent redo aortic valve replacement (AVR) and 4 patients had redo pulmonary valve replacement. Freedom from reoperation for AVR and more-than-mild AR at 10 and 20 years post-surgery were 89% (95% CI 81-94) and 85% (95% CI 74-92), respectively. Having longer aortic cross-clamp (hazard ratio 1.03, 95% CI 1.00-1.06; P = 0.05) and cardiopulmonary bypass times (hazard ratio 1.02, 95% CI 1.00-1.05; P = 0.05), and having a larger preoperative sinotubular junction diameter (hazard ratio 1.15, 95% CI 1.03-1.30; P = 0.02) were significant predictors of having redo AVR or significant AR at follow-up. CONCLUSIONS: With a 20-year freedom from redo AVR and greater-than-mild residual AR of 85%, the utilization of the Ross procedure in bicuspid aortic valve patients with pure AR should be considered.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Poh CL, Buratto E, Larobina M, et al. The Ross procedure in adults presenting with bicuspid aortic valve and pure aortic regurgitation: 85% freedom from reoperation at 20 years. Eur J Cardiothorac Surg. 2018. PMID: 29546380. doi:10.1093/ejcts/ezy073

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。